Novartis AG
Market Reports 📊 111 Reports
101. Global DNA Read, Write and Edit Market
The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.
102. Communicable Disease Market: A BCC Research Overview
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate of 3.8% for the period of 2019-2024.
103. Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
104. Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-202
105. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
106. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
107. Markets at a Glance: Pharmaceuticals
Examine the trends revolutionizing the pharmaceuticals sector along with an overview of active pharmaceutical ingredients (API), antipsychotic drugs, and neuroprotective agents.
108. Chronic Kidney Disease: Global Markets and Technologies Through 2023
According to BCC Research global market for chronic kidney disease should grow from $79.0 billion in 2018 to reach $95.0 billion by 2023 at a compound annual growth rate of 3.8%.
109. Colorectal Cancer Therapeutics: Global Markets
The global colorectal cancer therapeutics market should reach $18.5 billion by 2023 from $13.7 billion in 2018 at a compound annual growth rate of 6.1% for the period 2018 to 2023.
110. Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate of 9.3% from 2018 to 2023.
111. Antihypertensives: Global Markets to 2023
The global market for antihypertensive drugs should grow from nearly $26.3 billion in 2018 to $27.8 billion by 2023 with a compound annual growth rate (CAGR) of 1.1% for the period of 2018-2023.
